Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

McKesson
Harvard Business School
Colorcon
Medtronic
Express Scripts
AstraZeneca

Last Updated: December 7, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Apricoxib

See Plans and Pricing

« Back to Dashboard

What is the drug development status for Apricoxib?

Apricoxib is an investigational drug.

There have been 5 clinical trials for Apricoxib. The most recent clinical trial was a Phase 2 trial, which was initiated on August 1st 2008.

The most common disease conditions in clinical trials are Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, and Pancreatic Neoplasms. The leading clinical trial sponsors are Tragara Pharmaceuticals, Inc., Jonsson Comprehensive Cancer Center, and Martin Edelman, MD.

Recent Clinical Trials for Apricoxib
TitleSponsorPhase
Evaluation of Apricoxib (Selective Cyclooxygenase 2 Inhibition) in Modulating T Regulatory Cells of Patients With Early Stage Non-small Cell Lung CancerJonsson Comprehensive Cancer CenterN/A
0822GCC: Phase 2 Study of Efficacy and Safety of Apricoxib/Placebo With Docetaxel or Pemetrexed in Non-Small Cell Lung CancerTragara Pharmaceuticals, Inc.Phase 2
0822GCC: Phase 2 Study of Efficacy and Safety of Apricoxib/Placebo With Docetaxel or Pemetrexed in Non-Small Cell Lung CancerMartin Edelman, MDPhase 2

See all Apricoxib clinical trials

Clinical Trial Summary for Apricoxib

Top disease conditions for Apricoxib
Top clinical trial sponsors for Apricoxib

See all Apricoxib clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Merck
Boehringer Ingelheim
Moodys
Baxter
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.